﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Wed, 06 May 2026 21:43:03 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/May-2026/rss/4569</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/May-2026/rss/4569" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Michelle Powell]]></dc:creator><title><![CDATA[GLP-1 innovations: Guidance for pharmacist practice]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/glp-1-innovations-guidance-for-pharmacist-practice</link><description><![CDATA[  Christopher R. Piszczatoski, PharmD, BCPS  

   

 In recent years, GLP-1 receptor agonists have exploded in popularity and usage. Recent data as of 2024 indicates that 6% of U.S. patients ...]]></description><pubDate>Tue, 07 Apr 2026 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/glp-1-innovations-guidance-for-pharmacist-practice</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3951]]></dc:identifier></item></channel></rss>